Evidence map›Paper›PMID 25867635›Full record

ArticleJournal of visualized experiments : JoVE2015

Chitosan/interfering RNA nanoparticle mediated gene silencing in disease vector mosquito larvae.

Xin Zhang, Keshava Mysore, Ellen Flannery, Kristin Michel, David W Severson, Kun Yan Zhu, Molly Duman-Scheel

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Challenges of Robust RNAi-Mediated Gene Silencing inInternational journal of molecular sciences · 2024
    Article
  13. Review
  14. Outlook on RNAi-Based Strategies for ControllingPathogens (Basel, Switzerland) · 2023
    Review
  15. Article
  16. IPS (In-Plant System) Delivery of Double-StrandedInternational journal of molecular sciences · 2023
    Article
  17. Review
  18. Mosquito gene targeted RNAi studies for vector control.Functional & integrative genomics · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xin ZhangDivision of Biology, Kansas State University.
Keshava MysoreDepartment of Medical and Molecular Genetics, Indiana University School of Medicine; Eck Institute for Global Health, University of Notre Dame.
Ellen FlanneryEck Institute for Global Health, University of Notre Dame; Department of Biological Sciences, University of Notre Dame.
Kristin MichelDivision of Biology, Kansas State University.
David W SeversonEck Institute for Global Health, University of Notre Dame; Department of Biological Sciences, University of Notre Dame.
Kun Yan ZhuDepartment of Entomology, Kansas State University.
Molly Duman-ScheelDepartment of Medical and Molecular Genetics, Indiana University School of Medicine; Eck Institute for Global Health, University of Notre Dame; Department of Biological Sciences, University of Notre Dame; Molly.A.Scheel.2@nd.edu.

Funding

Analysis of the functions of axon guidance genes during vector mosquito developmeR01AI081795 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI SCHEEL, MOLLY DUMAN · 2009 to 2012
$1.5M
The function(s) of serpin-2 in mosquito immunity and physiologyR01AI095842 · NIAID · KANSAS STATE UNIVERSITY · PI MICHEL, KRISTIN · 2011 to 2014
$1.5M
NIAID NIH HHS R01 AI081795NIAID NIH HHS R01-AI081795NIAID NIH HHS R01 AI095842NIAID NIH HHS R01-AI095842
6 · The paper itself

Abstract

Vector mosquitoes inflict more human suffering than any other organism-and kill more than one million people each year. The mosquito genome projects facilitated research in new facets of mosquito biology, including functional genetic studies in the primary African malaria vector Anopheles gambiae and the dengue and yellow fever vector Aedes aegypti. RNA interference- (RNAi-) mediated gene silencing has been used to target genes of interest in both of these disease vector mosquito species. Here, we describe a procedure for preparation of chitosan/interfering RNA nanoparticles that are combined with food and ingested by larvae. This technically straightforward, high-throughput, and relatively inexpensive methodology, which is compatible with long double stranded RNA (dsRNA) or small interfering RNA (siRNA) molecules, has been used for the successful knockdown of a number of different genes in A. gambiae and A. aegypti larvae. Following larval feedings, knockdown, which is verified through qRT-PCR or in situ hybridization, can persist at least through the late pupal stage. This methodology may be applicable to a wide variety of mosquito and other insect species, including agricultural pests, as well as other non-model organisms. In addition to its utility in the research laboratory, in the future, chitosan, an inexpensive, non-toxic and biodegradable polymer, could potentially be utilized in the field.

Indexed as

AedesAnimalsAnophelesChitosanFemaleGene Knockdown TechniquesGene SilencingInsect VectorsLarvaMosquito ControlNanoparticlesPupaRNA, Double-StrandedRNA InterferenceRNA, Small InterferingChitosanRNA, Double-StrandedRNA, Small Interfering

Identifiers

PMID25867635
PMCPMC4401390

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.